Our standards are high, and our aseptic fill/finish services are comprehensive. Compliance is key. Our Cambridge and Lexington facilities and processes are designed to be compliant for viral vector-based gene therapy products under the FDA Code of Federal Regulations (Part 21) and the European Advanced Therapy Medicinal Products’ regulations.
Automated fillings solutions:
Please contact us to learn more about our viral vector late-phase and commercial services.
Learn more about our viral vector service capabilities.